Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and Tamoxifen Effects on Bone and Lipids in Breast Cancer
NCT00171704Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2005
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of letrozole in breast cancer, sponsored by Novartis. Started Apr 2005; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00171704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171704.